1765 related articles for article (PubMed ID: 30304291)
1. ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS?
Azzam RS
Arq Gastroenterol; 2018 Nov; 55Suppl 1(Suppl 1):85-91. PubMed ID: 30304291
[TBL] [Abstract][Full Text] [Related]
2. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
[TBL] [Abstract][Full Text] [Related]
3. AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review.
Yadlapati R; Gyawali CP; Pandolfino JE;
Clin Gastroenterol Hepatol; 2022 May; 20(5):984-994.e1. PubMed ID: 35123084
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and clinical characteristics of refractoriness to optimal proton pump inhibitor therapy in non-erosive reflux disease.
Ribolsi M; Cicala M; Zentilin P; Neri M; Mauro A; Efthymakis K; Petitti T; Savarino V; Penagini R
Aliment Pharmacol Ther; 2018 Nov; 48(10):1074-1081. PubMed ID: 30294924
[TBL] [Abstract][Full Text] [Related]
5. AGA Clinical Practice Update on the Diagnosis and Management of Extraesophageal Gastroesophageal Reflux Disease: Expert Review.
Chen JW; Vela MF; Peterson KA; Carlson DA
Clin Gastroenterol Hepatol; 2023 Jun; 21(6):1414-1421.e3. PubMed ID: 37061897
[TBL] [Abstract][Full Text] [Related]
6. Extra-esophageal gastroesophageal reflux disease and asthma: understanding this interplay.
Naik RD; Vaezi MF
Expert Rev Gastroenterol Hepatol; 2015 Jul; 9(7):969-82. PubMed ID: 26067887
[TBL] [Abstract][Full Text] [Related]
7. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
[TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitor-refractory gastroesophageal reflux disease: current diagnosis and management.
Frazzoni L; Fuccio L; Frazzoni M
Minerva Gastroenterol Dietol; 2017 Sep; 63(3):249-256. PubMed ID: 28251845
[TBL] [Abstract][Full Text] [Related]
9. Twice-daily proton pump inhibitor therapy does not decrease the frequency of reflux episodes during nocturnal recumbency in patients with refractory GERD: analysis of 200 patients using multichannel intraluminal impedance-pH testing.
Clayton SB; Rife CC; Singh ER; Kalbfleisch JH; Castell DO
Dis Esophagus; 2012; 25(8):682-6. PubMed ID: 22292567
[TBL] [Abstract][Full Text] [Related]
10. Most Patients With Gastroesophageal Reflux Disease Who Failed Proton Pump Inhibitor Therapy Also Have Functional Esophageal Disorders.
Abdallah J; George N; Yamasaki T; Ganocy S; Fass R
Clin Gastroenterol Hepatol; 2019 May; 17(6):1073-1080.e1. PubMed ID: 29913281
[TBL] [Abstract][Full Text] [Related]
11. Role of esophageal manometry and 24-h pH testing in patients with refractory reflux symptoms.
Jain M; Agrawal V
Indian J Gastroenterol; 2020 Apr; 39(2):165-170. PubMed ID: 32388711
[TBL] [Abstract][Full Text] [Related]
12. Gastroesophageal Reflux Disease: A Review.
Maret-Ouda J; Markar SR; Lagergren J
JAMA; 2020 Dec; 324(24):2536-2547. PubMed ID: 33351048
[TBL] [Abstract][Full Text] [Related]
13. Evaluation and Treatment of Patients with Persistent Reflux Symptoms Despite Proton Pump Inhibitor Treatment.
Spechler SJ
Gastroenterol Clin North Am; 2020 Sep; 49(3):437-450. PubMed ID: 32718563
[TBL] [Abstract][Full Text] [Related]
14. Extra-esophageal manifestations of GERD: who responds to GERD therapy?
Naik RD; Vaezi MF
Curr Gastroenterol Rep; 2013 Apr; 15(4):318. PubMed ID: 23435747
[TBL] [Abstract][Full Text] [Related]
15. Refractory gastroesophageal reflux disease.
Moraes-Filho JP
Arq Gastroenterol; 2012 Dec; 49(4):296-301. PubMed ID: 23329226
[TBL] [Abstract][Full Text] [Related]
16. Patients with refractory reflux symptoms often do not have GERD.
Herregods TV; Troelstra M; Weijenborg PW; Bredenoord AJ; Smout AJ
Neurogastroenterol Motil; 2015 Sep; 27(9):1267-73. PubMed ID: 26088946
[TBL] [Abstract][Full Text] [Related]
17. Limited ability of the proton-pump inhibitor test to identify patients with gastroesophageal reflux disease.
Bytzer P; Jones R; Vakil N; Junghard O; Lind T; Wernersson B; Dent J
Clin Gastroenterol Hepatol; 2012 Dec; 10(12):1360-6. PubMed ID: 22813439
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitor resistance, the real challenge in gastro-esophageal reflux disease.
Cicala M; Emerenziani S; Guarino MP; Ribolsi M
World J Gastroenterol; 2013 Oct; 19(39):6529-35. PubMed ID: 24151377
[TBL] [Abstract][Full Text] [Related]
19. Use of Esophageal pH Monitoring to Minimize Proton-Pump Inhibitor Utilization in Patients with Gastroesophageal Reflux Symptoms.
Triadafilopoulos G; Zikos T; Regalia K; Sonu I; Fernandez-Becker NQ; Nguyen L; Nandwani MCR; Clarke JO
Dig Dis Sci; 2018 Oct; 63(10):2673-2680. PubMed ID: 29959725
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
